GLOBUS MEDICAL, INC. (GMED) Return on equity 2016–2025
GLOBUS MEDICAL, INC. (GMED) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
11.8%FY2025 · since FY2016: 12.5% → 11.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 11.8% | +9.3 pp |
| FY2024 | 2.5% | -0.6 pp |
| FY2023 | 3.1% | -7.2 pp |
| FY2022 | 10.3% | +1.7 pp |
| FY2021 | 8.6% | +1.8 pp |
| FY2020 | 6.8% | -4.3 pp |
| FY2019 | 11.1% | -2.1 pp |
| FY2018 | 13.2% | +2.1 pp |
| FY2017 | 11.1% | -1.4 pp |
| FY2016 | 12.5% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More GMED financial trends
GMED RevenueGMED Net incomeGMED Net marginGMED Gross profitGMED Gross marginGMED Operating incomeGMED Operating marginGMED Operating cash flowGMED Free cash flowGMED Capital expendituresGMED Stock buybacksGMED Dividends paidGMED Total assetsGMED Total liabilitiesGMED Shareholders’ equityGMED overview →